Venous and arterial thromboembolism in patients with cancer treated with immune checkpoint inhibitor therapy
Patients with cancer are at an increased risk of venous and arterial thromboembolism (VTE/ATE) . A number of factors...
AUTHORS
Ingrid Pabinger
Professur für Hämostaseologie, Universitätsklinik für Innere Medizin I, Klinische Abteilung für Hämatologie und Hämostaseologie, Wien
Ingrid Pabinger at ISTH 2018
Ingrid Pabinger Professur für Hämostaseologie, Universitätsklinik für Innere Medizin I, Klinische Abteilung für...
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer
Cancer is a well-known risk factor for the occurrence of venous thromboembolism. In contrast, little research has been...